Project: A novel platform enabling prediction of disease progression in heart failure patients.

Acronym HeartAssess (Reference Number: 114585)
Duration 01/04/2021 - 01/04/2024
Project Topic HeartAssess will deliver a prognostic tool to predict disease progression in heart failure (HF) patients. The platform assesses cardiometabolic parameters by integrating data from two sensors and visualizing analyzed results on a user-friendly dashboard. An AI algorithm will be trained to predict disease progression. By the end of the project, the platform’s predictive value will have been validated in a feasibility pilot study and will be ready for a pivotal trial required to enter the clinic.
Network Eurostars 2
Call Eurostars Cut–off 14

Project partner